The Impact of the Coronavirus Disease 2019 Pandemic on Adherence to Ocular Hypotensive Medication in Patients with Primary Open-Angle Glaucoma.

ABSTRACT:

Purpose

Emerging evidence suggests that the coronavirus disease 2019 (COVID-19) pandemic is disrupting health behaviors such as medication adherence. The objective of this study was to determine whether adherence to ocular hypotensive medication was affected by the pandemic and to identify factors associated with this change.

Design

In this cohort study, we used a controlled interrupted time series design in which the interruption was the declaration of the COVID-19 pandemic in the United States on March 13, 2020. The 300-day monitoring period, which evenly bracketed this declaration, started on October 16, 2019, and ended on August 10, 2020.

Participants

Patients with primary open-angle glaucoma enrolled in an ongoing longitudinal National Institutes of Health-funded

SUBMITTER: Racette L 

PROVIDER: S-EPMC8523310 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature